Performance
Day's Low
Day's High
₹45.74₹48.7952 Week's Low
52 Week's High
₹21.5₹56.5
| Returns % | |
| 1 Month Return | + 48.22 % |
| 3 Month Return | + 40.15 % |
| 1 Year Return | + 86.95 % |
| Market Stats | |
| Previous Close | ₹47.86 |
| Open | ₹48.15 |
| Volume | 14.36L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,073.31Cr |
Key Statistics
| P/E Ratio | 170.93 |
| PEG Ratio | 117.88 |
| Market Cap | ₹1,073.31 Cr |
| P/B Ratio | 0.63 |
| EPS | 0.22 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 0.47 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,073.31 Cr | 46.7% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
| BUY | ₹13,431.32 Cr | 380.53% | 0.51 | ₹314 Cr | ₹2,177 Cr | |
| BUY | ₹4,595.73 Cr | 9.67% | 0.63 | ₹94 Cr | ₹1,081 Cr | |
| NA | ₹17.90 Cr | 19.66% | 0.69 | NA | NA | |
| NA | ₹148.30 Cr | 14.52% | 0.59 | NA | NA |
Company Information
Share Price: ₹46.62 per share as on 18 Sep, 2024 04:01 PM
Market Capitalisation: ₹1,073.31Cr as of today
Revenue: ₹358.85Cr as on June 2024 (Q2 24)
Net Profit: ₹2.97Cr as on June 2024 (Q2 24)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
| Organisation | Nectar Lifescience Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Nectar Lifescience Ltd
Nectar Lifesciences Shareholders See 85% Return in Last Year - 12 Jun, 2024
Despite a decline in earnings over the last five years, Nectar Lifesciences has rewarded shareholders with an impressive total return of 85% in the past twelve months. The market's forward-looking nature is evident as the share price rose by 16% per year despite revenue shrinking by 13% annually.
Nectar Lifescience Q4 Net Sales Up 13.52% YoY - 20 May, 2024
Nectar Lifescience's consolidated net sales for March 2024 stood at Rs. 441.37 crore, up 13.52% YoY. However, the quarterly net profit decreased by 83.9% YoY to Rs. 0.59 crore. The EPS also decreased from Rs. 0.16 in March 2023 to Rs. 0.03 in March 2024. Nectar Lifescience shares closed at Rs. 33.75 on May 17, 2024 (NSE) and have given returns of 19.47% over the last 6 months and 98.53% over the last 12 months.
Nectar Lifescience Q4 2024 Net Sales Up 13.52% - 17 May, 2024
Nectar Lifescience's standalone net sales for March 2024 increased by 13.52% YoY, while quarterly net profit decreased by 88.83%. The company's EPS also decreased from Rs. 0.24 to Rs. 0.03 in the same period. However, Nectar Lifescience shares have given returns of 35.45% over the last six months and 98.26% over the last twelve months.
Insights on Nectar Lifescience Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 21.63% to 21.91% in Jun 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NECLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 0.59 Cr → 2.97 Cr (in ₹), with an average increase of 80.1% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 44.35% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 146.7% return, outperforming this stock by 82.2%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 1.90% to 1.66% in Jun 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 452.65 Cr → 359.85 Cr (in ₹), with an average decrease of 10.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, NECLIFE stock has moved down by -9.8%
Company Financials
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.35% | 0.00 | |
| Foreign Institutions | 1.66% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 21.91% | 1.33 | |
| Others | 32.08% |
Key Indicators
Nectar Lifescience Ltd Valuation
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Industry (58.70x)
September 17, 2024
Today (170.93x)
September 17, 2024
Highest (403.33x)
August 26, 2020
Earnings and Dividends
Nectar Lifescience Ltd Earnings Results
Nectar Lifescience Ltd’s net profit jumped 63.19% since last year same period to ₹2.97Cr in the Q1 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 403.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsNectar Lifescience Ltd Dividends July,2020
In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.10%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Nectar Lifescience Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Nectar Lifescience Ltd shares.
Nectar Lifescience Ltd (NECLIFE) share price today is ₹46.62
Nectar Lifescience Ltd is listed on NSE
Nectar Lifescience Ltd is listed on BSE
- Today’s highest price of Nectar Lifescience Ltd is ₹48.79.
- Today’s lowest price of Nectar Lifescience Ltd is ₹45.74.
PE Ratio of Nectar Lifescience Ltd is 170.93
PE ratio = Nectar Lifescience Ltd Market price per share / Nectar Lifescience Ltd Earnings per share
Today’s traded volume of Nectar Lifescience Ltd(NECLIFE) is 14.36L.
Today’s market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹1073.31Cr.
| Nectar Lifescience Ltd(NECLIFE | Price |
|---|---|
52 Week High | ₹56.5 |
52 Week Low | ₹21.5 |
Nectar Lifescience Ltd(NECLIFE) share price is ₹46.62. It is down -17.49% from its 52 Week High price of ₹56.5
Nectar Lifescience Ltd(NECLIFE) share price is ₹46.62. It is up 116.84% from its 52 Week Low price of ₹21.5
| Nectar Lifescience Ltd(NECLIFE | Returns |
|---|---|
1 Day Returns | -1.24% |
1 Month Returns | 48.22% |
3 Month Returns | 40.15% |
1 Year Returns | 86.95% |